메뉴 건너뛰기




Volumn 26, Issue 1, 2015, Pages 40-48

Is AMPK the savior of the failing heart?

Author keywords

AMP activated protein kinase (AMPK); Cardiac metabolism; Myocardial ATP production; Systolic heart failure

Indexed keywords

FATTY ACID; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; TRANSCRIPTION FACTOR FOXO; 5 AMINO 4 IMIDAZOLECARBOXAMIDE; AICA RIBONUCLEOTIDE; METFORMIN; RIBONUCLEOTIDE;

EID: 84920596800     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2014.11.001     Document Type: Review
Times cited : (81)

References (112)
  • 1
    • 84893651437 scopus 로고    scopus 로고
    • Heart disease and stroke statistics: 2014 update: a report from the American Heart Association
    • Go A.S., et al. Heart disease and stroke statistics: 2014 update: a report from the American Heart Association. Circulation 2014, 129:e28-e292.
    • (2014) Circulation , vol.129 , pp. e28-e292
    • Go, A.S.1
  • 2
    • 33746088001 scopus 로고    scopus 로고
    • Trends in prevalence and outcome of heart failure with preserved ejection fraction
    • Owan T.E., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N. Engl. J. Med. 2006, 355:251-259.
    • (2006) N. Engl. J. Med. , vol.355 , pp. 251-259
    • Owan, T.E.1
  • 3
    • 84885845957 scopus 로고    scopus 로고
    • 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines
    • Yancy C.W., et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2013, 128:240-327.
    • (2013) Circulation , vol.128 , pp. 240-327
    • Yancy, C.W.1
  • 4
    • 33644554148 scopus 로고    scopus 로고
    • Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management
    • Arnold J.M.O., et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management. Can. J. Cardiol. 2006, 22:23-45.
    • (2006) Can. J. Cardiol. , vol.22 , pp. 23-45
    • Arnold, J.M.O.1
  • 5
    • 0033553875 scopus 로고    scopus 로고
    • Profile for estimating risk of heart failure
    • Kannel W.B., et al. Profile for estimating risk of heart failure. Arch. Intern. Med. 1999, 159:1197-1204.
    • (1999) Arch. Intern. Med. , vol.159 , pp. 1197-1204
    • Kannel, W.B.1
  • 6
    • 79551484153 scopus 로고    scopus 로고
    • Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?
    • Ezekowitz J.A., et al. Trends in heart failure care: has the incident diagnosis of heart failure shifted from the hospital to the emergency department and outpatient clinics?. Eur. J. Heart Fail. 2011, 13:142-147.
    • (2011) Eur. J. Heart Fail. , vol.13 , pp. 142-147
    • Ezekowitz, J.A.1
  • 7
    • 12444280925 scopus 로고    scopus 로고
    • Impact of specialist follow-up in outpatients with congestive heart failure
    • Ezekowitz J.A., et al. Impact of specialist follow-up in outpatients with congestive heart failure. CMAJ 2005, 172:189-194.
    • (2005) CMAJ , vol.172 , pp. 189-194
    • Ezekowitz, J.A.1
  • 8
    • 84888227537 scopus 로고    scopus 로고
    • Pathophysiology and etiology of heart failure
    • Johnson F.L. Pathophysiology and etiology of heart failure. Cardiol. Clin. 2014, 32:9-19.
    • (2014) Cardiol. Clin. , vol.32 , pp. 9-19
    • Johnson, F.L.1
  • 9
    • 65549145093 scopus 로고    scopus 로고
    • 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation
    • Hunt S.A., et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009, 119:391-479.
    • (2009) Circulation , vol.119 , pp. 391-479
    • Hunt, S.A.1
  • 10
    • 77953390121 scopus 로고    scopus 로고
    • Treatment and risk in heart failure: gaps in evidence or quality?
    • Peterson P.N., et al. Treatment and risk in heart failure: gaps in evidence or quality?. Circ. Cardiovasc. Qual. Outcomes 2010, 3:309-315.
    • (2010) Circ. Cardiovasc. Qual. Outcomes , vol.3 , pp. 309-315
    • Peterson, P.N.1
  • 11
    • 34548525319 scopus 로고    scopus 로고
    • How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology
    • Paulus W.J., et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur. Heart J. 2007, 28:2539-2550.
    • (2007) Eur. Heart J. , vol.28 , pp. 2539-2550
    • Paulus, W.J.1
  • 12
    • 33748042938 scopus 로고    scopus 로고
    • Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey
    • Abhayaratna W.P., et al. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart 2006, 92:1259-1264.
    • (2006) Heart , vol.92 , pp. 1259-1264
    • Abhayaratna, W.P.1
  • 13
    • 84880118241 scopus 로고    scopus 로고
    • The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis
    • Meta-analysis Global Group in Chronic Heart Failure
    • The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur. Heart J. 2012, 33:1750-1757. Meta-analysis Global Group in Chronic Heart Failure.
    • (2012) Eur. Heart J. , vol.33 , pp. 1750-1757
  • 14
    • 84870241098 scopus 로고    scopus 로고
    • Altered sarcoplasmic reticulum calcium cycling: targets for heart failure therapy
    • Kho C., et al. Altered sarcoplasmic reticulum calcium cycling: targets for heart failure therapy. Nat. Rev. Cardiol. 2012, 9:717-733.
    • (2012) Nat. Rev. Cardiol. , vol.9 , pp. 717-733
    • Kho, C.1
  • 15
    • 84890798751 scopus 로고    scopus 로고
    • Cell death in the myocardium: my heart won't go on
    • Orogo A.M., Gustafsson Å.B. Cell death in the myocardium: my heart won't go on. IUBMB Life 2013, 65:651-656.
    • (2013) IUBMB Life , vol.65 , pp. 651-656
    • Orogo, A.M.1    Gustafsson, A.B.2
  • 16
    • 0032573115 scopus 로고    scopus 로고
    • Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds
    • Mann D.L., Spinale F.G. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. Circulation 1998, 98:1699-1702.
    • (1998) Circulation , vol.98 , pp. 1699-1702
    • Mann, D.L.1    Spinale, F.G.2
  • 17
    • 80052735260 scopus 로고    scopus 로고
    • Drug therapy of heart failure: an immunologic view
    • El Desoky E.S. Drug therapy of heart failure: an immunologic view. Am. J. Ther. 2011, 18:416-425.
    • (2011) Am. J. Ther. , vol.18 , pp. 416-425
    • El Desoky, E.S.1
  • 18
    • 84919967502 scopus 로고    scopus 로고
    • Murine models of diastolic dysfunction and heart failure with preserved ejection fraction
    • Published online September 12, 2014
    • Horgan S., et al. Murine models of diastolic dysfunction and heart failure with preserved ejection fraction. J. Card. Fail. 2014, Published online September 12, 2014. http://dx.doi.org/0.1016/j.cardfail.2014.09.001.
    • (2014) J. Card. Fail.
    • Horgan, S.1
  • 19
    • 84874075155 scopus 로고    scopus 로고
    • Investigating cardiac energetics in heart failure
    • Lygate C.A., et al. Investigating cardiac energetics in heart failure. Exp. Physiol. 2013, 98:601-605.
    • (2013) Exp. Physiol. , vol.98 , pp. 601-605
    • Lygate, C.A.1
  • 20
    • 74949133862 scopus 로고    scopus 로고
    • Myocardial fatty acid metabolism in health and disease
    • Lopaschuk G.D., et al. Myocardial fatty acid metabolism in health and disease. Physiol. Rev. 2010, 90:207-258.
    • (2010) Physiol. Rev. , vol.90 , pp. 207-258
    • Lopaschuk, G.D.1
  • 21
    • 21244492310 scopus 로고    scopus 로고
    • Myocardial substrate metabolism in the normal and failing heart
    • Stanley W.C., et al. Myocardial substrate metabolism in the normal and failing heart. Physiol. Rev. 2005, 85:1093-1129.
    • (2005) Physiol. Rev. , vol.85 , pp. 1093-1129
    • Stanley, W.C.1
  • 22
    • 84875068490 scopus 로고    scopus 로고
    • Targeting mitochondrial oxidative metabolism as an approach to treat heart failure
    • Fillmore N., Lopaschuk G.D. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochim. Biophys. Acta 2013, 1833:857-865.
    • (2013) Biochim. Biophys. Acta , vol.1833 , pp. 857-865
    • Fillmore, N.1    Lopaschuk, G.D.2
  • 23
    • 0027978916 scopus 로고
    • Regulation of fatty acid oxidation in the mammalian heart in health and disease
    • Lopaschuk G.D., et al. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1994, 1213:263-276.
    • (1994) Biochim. Biophys. Acta , vol.1213 , pp. 263-276
    • Lopaschuk, G.D.1
  • 24
    • 3042711537 scopus 로고    scopus 로고
    • Linking gene expression to function: metabolic flexibility in the normal and diseased heart
    • Taegtmeyer H., et al. Linking gene expression to function: metabolic flexibility in the normal and diseased heart. Ann. N. Y. Acad. Sci. 2004, 1015:202-213.
    • (2004) Ann. N. Y. Acad. Sci. , vol.1015 , pp. 202-213
    • Taegtmeyer, H.1
  • 25
    • 84908133657 scopus 로고    scopus 로고
    • Chronic high-fat diet-induced obesity decreased survival and increased hypertrophy of rats with experimental eccentric hypertrophy from chronic aortic regurgitation
    • Dhahri W., et al. Chronic high-fat diet-induced obesity decreased survival and increased hypertrophy of rats with experimental eccentric hypertrophy from chronic aortic regurgitation. BMC Cardiovasc. Disord. 2014, 14:123.
    • (2014) BMC Cardiovasc. Disord. , vol.14 , pp. 123
    • Dhahri, W.1
  • 26
    • 36849040149 scopus 로고    scopus 로고
    • Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy
    • Neglia D., et al. Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H3270-H3278.
    • (2007) Am. J. Physiol. Heart Circ. Physiol. , vol.293 , pp. H3270-H3278
    • Neglia, D.1
  • 27
    • 84879583225 scopus 로고    scopus 로고
    • Cardiomyocyte ATP production, metabolic flexibility, and survival require calcium flux through cardiac ryanodine receptors in vivo
    • Bround M.J., et al. Cardiomyocyte ATP production, metabolic flexibility, and survival require calcium flux through cardiac ryanodine receptors in vivo. J. Biol. Chem. 2013, 288:18975-18986.
    • (2013) J. Biol. Chem. , vol.288 , pp. 18975-18986
    • Bround, M.J.1
  • 28
    • 33947239659 scopus 로고    scopus 로고
    • The failing heart: an engine out of fuel
    • Neubauer S. The failing heart: an engine out of fuel. N. Engl. J. Med. 2007, 356:1140-1151.
    • (2007) N. Engl. J. Med. , vol.356 , pp. 1140-1151
    • Neubauer, S.1
  • 29
    • 10944247187 scopus 로고    scopus 로고
    • The AMP-activated protein kinase pathway: new players upstream and downstream
    • Hardie D. The AMP-activated protein kinase pathway: new players upstream and downstream. J. Cell Sci. 2004, 1:5479-5487.
    • (2004) J. Cell Sci. , vol.1 , pp. 5479-5487
    • Hardie, D.1
  • 30
    • 84908101883 scopus 로고    scopus 로고
    • AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes
    • Balteau M., et al. AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2014, 307:H1120-H1133.
    • (2014) Am. J. Physiol. Heart Circ. Physiol. , vol.307 , pp. H1120-H1133
    • Balteau, M.1
  • 31
    • 0031007065 scopus 로고    scopus 로고
    • The AMP-activated protein kinase: fuel gauge of the mammalian cell?
    • Hardie D.G., Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell?. Eur. J. Biochem. 1997, 246:259-273.
    • (1997) Eur. J. Biochem. , vol.246 , pp. 259-273
    • Hardie, D.G.1    Carling, D.2
  • 32
    • 33845475621 scopus 로고    scopus 로고
    • Role of AMP-activated protein kinase in healthy and diseased hearts
    • Dolinsky V.W., Dyck J.R.B. Role of AMP-activated protein kinase in healthy and diseased hearts. Am. J. Physiol. Heart Circ. Physiol. 2006, 291:2557-2569.
    • (2006) Am. J. Physiol. Heart Circ. Physiol. , vol.291 , pp. 2557-2569
    • Dolinsky, V.W.1    Dyck, J.R.B.2
  • 33
    • 0029093341 scopus 로고
    • High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase
    • Kudo N., et al. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. J. Biol. Chem. 1995, 270:17513-17520.
    • (1995) J. Biol. Chem. , vol.270 , pp. 17513-17520
    • Kudo, N.1
  • 34
    • 0037677773 scopus 로고    scopus 로고
    • Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling
    • Luiken J.J., et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003, 52:1627-1634.
    • (2003) Diabetes , vol.52 , pp. 1627-1634
    • Luiken, J.J.1
  • 35
    • 84897394439 scopus 로고    scopus 로고
    • Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy
    • Fillmore N., et al. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br. J. Pharmacol. 2014, 171:2080-2090.
    • (2014) Br. J. Pharmacol. , vol.171 , pp. 2080-2090
    • Fillmore, N.1
  • 36
    • 0036087776 scopus 로고    scopus 로고
    • Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle
    • Park S.H., et al. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J. Appl. Physiol. 2002, 92:2475-2482.
    • (2002) J. Appl. Physiol. , vol.92 , pp. 2475-2482
    • Park, S.H.1
  • 37
    • 0034687210 scopus 로고    scopus 로고
    • Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
    • Marsin A.S., et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr. Biol. 2000, 10:1247-1255.
    • (2000) Curr. Biol. , vol.10 , pp. 1247-1255
    • Marsin, A.S.1
  • 38
    • 0029885660 scopus 로고    scopus 로고
    • Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR: an activator of AMP-activated protein kinase
    • Young M.E., et al. Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR: an activator of AMP-activated protein kinase. FEBS Lett. 1996, 382:43-47.
    • (1996) FEBS Lett. , vol.382 , pp. 43-47
    • Young, M.E.1
  • 39
    • 0032881635 scopus 로고    scopus 로고
    • Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR
    • Russell R.R., 3rd, et al. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol. 1999, 277:H643-H649.
    • (1999) Am. J. Physiol. , vol.277 , pp. H643-H649
    • Russell III, R.R.1
  • 40
    • 84894362626 scopus 로고    scopus 로고
    • Cardiomyocyte health: adapting to metabolic changes through autophagy
    • Kubli D.A., Gustafsson A.B. Cardiomyocyte health: adapting to metabolic changes through autophagy. Trends Endocrinol. Metab. 2014, 25:156-164.
    • (2014) Trends Endocrinol. Metab. , vol.25 , pp. 156-164
    • Kubli, D.A.1    Gustafsson, A.B.2
  • 41
    • 84856470679 scopus 로고    scopus 로고
    • PGC-1 coactivators in the cardiovascular system
    • Patten I.S., Arany Z. PGC-1 coactivators in the cardiovascular system. Trends Endocrinol. Metab. 2012, 23:90-97.
    • (2012) Trends Endocrinol. Metab. , vol.23 , pp. 90-97
    • Patten, I.S.1    Arany, Z.2
  • 42
    • 67650914230 scopus 로고    scopus 로고
    • AMPK in health and disease
    • Steinberg G.R., Kemp B.E. AMPK in health and disease. Physiol. Rev. 2009, 89:1025-1078.
    • (2009) Physiol. Rev. , vol.89 , pp. 1025-1078
    • Steinberg, G.R.1    Kemp, B.E.2
  • 43
    • 33749999530 scopus 로고    scopus 로고
    • Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
    • St-Pierre J., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006, 127:397-408.
    • (2006) Cell , vol.127 , pp. 397-408
    • St-Pierre, J.1
  • 44
    • 34547545892 scopus 로고    scopus 로고
    • AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
    • Jäger S., et al. AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12017-12022.
    • (2007) Proc. Natl. Acad. Sci. U.S.A. , vol.104 , pp. 12017-12022
    • Jäger, S.1
  • 45
    • 33845399894 scopus 로고    scopus 로고
    • Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha
    • Lagouge M., et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127:1109-1122.
    • (2006) Cell , vol.127 , pp. 1109-1122
    • Lagouge, M.1
  • 46
    • 80052812434 scopus 로고    scopus 로고
    • The PGC-1 cascade as a therapeutic target for heart failure
    • Schilling J., Kelly D.P. The PGC-1 cascade as a therapeutic target for heart failure. J. Mol. Cell. Cardiol. 2011, 51:578-583.
    • (2011) J. Mol. Cell. Cardiol. , vol.51 , pp. 578-583
    • Schilling, J.1    Kelly, D.P.2
  • 47
    • 77951924231 scopus 로고    scopus 로고
    • The FoxO family in cardiac function and dysfunction
    • Ronnebaum S.M., Patterson C. The FoxO family in cardiac function and dysfunction. Annu. Rev. Physiol. 2010, 72:81-94.
    • (2010) Annu. Rev. Physiol. , vol.72 , pp. 81-94
    • Ronnebaum, S.M.1    Patterson, C.2
  • 48
    • 70350500068 scopus 로고    scopus 로고
    • FoxO transcription factors promote autophagy in cardiomyocytes
    • Sengupta A., et al. FoxO transcription factors promote autophagy in cardiomyocytes. J. Biol. Chem. 2009, 284:28319-28331.
    • (2009) J. Biol. Chem. , vol.284 , pp. 28319-28331
    • Sengupta, A.1
  • 49
    • 0037136563 scopus 로고    scopus 로고
    • Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
    • Kops G.J., et al. Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 2002, 419:316-321.
    • (2002) Nature , vol.419 , pp. 316-321
    • Kops, G.J.1
  • 50
    • 0038187621 scopus 로고    scopus 로고
    • Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction
    • Puigserver P., et al. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature 2003, 423:550-555.
    • (2003) Nature , vol.423 , pp. 550-555
    • Puigserver, P.1
  • 51
    • 41149126078 scopus 로고    scopus 로고
    • Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism
    • Philip-Couderc P., et al. Forkhead transcription factors coordinate expression of myocardial KATP channel subunits and energy metabolism. Circ. Res. 2008, 102:e20-e35.
    • (2008) Circ. Res. , vol.102 , pp. e20-e35
    • Philip-Couderc, P.1
  • 52
    • 33746017379 scopus 로고    scopus 로고
    • FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity
    • Armoni M., et al. FOXO1 represses peroxisome proliferator-activated receptor-gamma1 and -gamma2 gene promoters in primary adipocytes. A novel paradigm to increase insulin sensitivity. J. Biol. Chem. 2006, 281:19881-19891.
    • (2006) J. Biol. Chem. , vol.281 , pp. 19881-19891
    • Armoni, M.1
  • 53
    • 0037342151 scopus 로고    scopus 로고
    • Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR
    • Daitoku H., et al. Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 2003, 52:642-649.
    • (2003) Diabetes , vol.52 , pp. 642-649
    • Daitoku, H.1
  • 54
    • 84872848906 scopus 로고    scopus 로고
    • FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation
    • Sengupta A., et al. FoxO1 and FoxM1 transcription factors have antagonistic functions in neonatal cardiomyocyte cell-cycle withdrawal and IGF1 gene regulation. Circ. Res. 2013, 112:267-277.
    • (2013) Circ. Res. , vol.112 , pp. 267-277
    • Sengupta, A.1
  • 55
    • 38849098449 scopus 로고    scopus 로고
    • Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells
    • Dixit M., et al. Shear stress-induced activation of the AMP-activated protein kinase regulates FoxO1a and angiopoietin-2 in endothelial cells. Cardiovasc. Res. 2008, 77:160-168.
    • (2008) Cardiovasc. Res. , vol.77 , pp. 160-168
    • Dixit, M.1
  • 56
    • 63849162173 scopus 로고    scopus 로고
    • AMP-activated protein kinase: a core signalling pathway in the heart
    • Kim A.S., et al. AMP-activated protein kinase: a core signalling pathway in the heart. Acta Physiol. 2009, 196:37-53.
    • (2009) Acta Physiol. , vol.196 , pp. 37-53
    • Kim, A.S.1
  • 57
    • 0035797839 scopus 로고    scopus 로고
    • Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy
    • Tian R., et al. Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 2001, 104:1664-1669.
    • (2001) Circulation , vol.104 , pp. 1664-1669
    • Tian, R.1
  • 58
    • 84902369145 scopus 로고    scopus 로고
    • Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies
    • Huang X., et al. Regulatory effect of AMP-activated protein kinase on pulmonary hypertension induced by chronic hypoxia in rats: in vivo and in vitro studies. Mol. Biol. Rep. 2014, 41:4031-4041.
    • (2014) Mol. Biol. Rep. , vol.41 , pp. 4031-4041
    • Huang, X.1
  • 59
    • 1142297593 scopus 로고    scopus 로고
    • Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection
    • Nishino Y., et al. Ischemic preconditioning activates AMPK in a PKC-dependent manner and induces GLUT4 up-regulation in the late phase of cardioprotection. Cardiovasc. Res. 2004, 61:610-619.
    • (2004) Cardiovasc. Res. , vol.61 , pp. 610-619
    • Nishino, Y.1
  • 60
    • 84862808312 scopus 로고    scopus 로고
    • AMPK isoform expression in the normal and failing hearts
    • Kim M., et al. AMPK isoform expression in the normal and failing hearts. J. Mol. Cell. Cardiol. 2012, 52:1066-1073.
    • (2012) J. Mol. Cell. Cardiol. , vol.52 , pp. 1066-1073
    • Kim, M.1
  • 61
    • 84905095362 scopus 로고    scopus 로고
    • Downregulation of Sirt1 as aging change in advanced heart failure
    • Lu T.M., et al. Downregulation of Sirt1 as aging change in advanced heart failure. J. Biomed. Sci. 2014, 21:57.
    • (2014) J. Biomed. Sci. , vol.21 , pp. 57
    • Lu, T.M.1
  • 62
    • 33947526130 scopus 로고    scopus 로고
    • AMP-activated protein kinase in the heart: role during health and disease
    • Arad M., et al. AMP-activated protein kinase in the heart: role during health and disease. Circ. Res. 2007, 100:474-488.
    • (2007) Circ. Res. , vol.100 , pp. 474-488
    • Arad, M.1
  • 63
    • 33745204925 scopus 로고    scopus 로고
    • AMPK alterations in cardiac physiology and pathology: enemy or ally?
    • Dyck J.R., Lopaschuk G.D. AMPK alterations in cardiac physiology and pathology: enemy or ally?. J. Physiol. 2006, 574:95-112.
    • (2006) J. Physiol. , vol.574 , pp. 95-112
    • Dyck, J.R.1    Lopaschuk, G.D.2
  • 64
    • 78149279712 scopus 로고    scopus 로고
    • AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury
    • Russell R.R., 3rd, et al. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest. 2004, 114:495-503.
    • (2004) J. Clin. Invest. , vol.114 , pp. 495-503
    • Russell III, R.R.1
  • 65
    • 84885220975 scopus 로고    scopus 로고
    • Metabolic and structural impairment of skeletal muscle in heart failure
    • Zizola C.P., Schulze P.C. Metabolic and structural impairment of skeletal muscle in heart failure. Heart Fail. Rev. 2013, 18:623-630.
    • (2013) Heart Fail. Rev. , vol.18 , pp. 623-630
    • Zizola, C.P.1    Schulze, P.C.2
  • 66
    • 57749083482 scopus 로고    scopus 로고
    • Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase
    • Stuck B.J., et al. Metabolic switch and hypertrophy of cardiomyocytes following treatment with angiotensin II are prevented by AMP-activated protein kinase. J. Biol. Chem. 2008, 283:32562-32569.
    • (2008) J. Biol. Chem. , vol.283 , pp. 32562-32569
    • Stuck, B.J.1
  • 67
    • 59449085388 scopus 로고    scopus 로고
    • Energy metabolism in heart failure and remodelling
    • Ingwall J.S. Energy metabolism in heart failure and remodelling. Cardiovasc. Res. 2009, 81:412-419.
    • (2009) Cardiovasc. Res. , vol.81 , pp. 412-419
    • Ingwall, J.S.1
  • 68
    • 84887490616 scopus 로고    scopus 로고
    • Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy
    • Zhang L., et al. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circ. Heart Fail. 2013, 6:1039-1048.
    • (2013) Circ. Heart Fail. , vol.6 , pp. 1039-1048
    • Zhang, L.1
  • 69
    • 84874672555 scopus 로고    scopus 로고
    • Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload
    • Zhabyeyev P., et al. Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. Cardiovasc. Res. 2013, 97:676-685.
    • (2013) Cardiovasc. Res. , vol.97 , pp. 676-685
    • Zhabyeyev, P.1
  • 71
    • 33745627066 scopus 로고    scopus 로고
    • Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha
    • Arany Z., et al. Transverse aortic constriction leads to accelerated heart failure in mice lacking PPAR-gamma coactivator 1alpha. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10086-10091.
    • (2006) Proc. Natl. Acad. Sci. U.S.A. , vol.103 , pp. 10086-10091
    • Arany, Z.1
  • 72
    • 84881419891 scopus 로고    scopus 로고
    • Metabolic remodeling in chronic heart failure
    • Wang J., Guo T. Metabolic remodeling in chronic heart failure. J. Zhejiang Univ. Sci. B 2013, 14:688-695.
    • (2013) J. Zhejiang Univ. Sci. B , vol.14 , pp. 688-695
    • Wang, J.1    Guo, T.2
  • 73
    • 70349633673 scopus 로고    scopus 로고
    • Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin
    • Li X.N., et al. Activation of the AMPK-FOXO3 pathway reduces fatty acid-induced increase in intracellular reactive oxygen species by upregulating thioredoxin. Diabetes 2009, 58:2246-2257.
    • (2009) Diabetes , vol.58 , pp. 2246-2257
    • Li, X.N.1
  • 74
    • 77953392525 scopus 로고    scopus 로고
    • A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3
    • Wang J., et al. A novel AMPK activator from Chinese herb medicine and ischemia phosphorylate the cardiac transcription factor FOXO3. Int. J. Physiol. Pathophysiol. Pharmacol. 2009, 1:116-126.
    • (2009) Int. J. Physiol. Pathophysiol. Pharmacol. , vol.1 , pp. 116-126
    • Wang, J.1
  • 75
    • 84874523611 scopus 로고    scopus 로고
    • Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway
    • Kanamori H., et al. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am. J. Pathol. 2013, 182:701-713.
    • (2013) Am. J. Pathol. , vol.182 , pp. 701-713
    • Kanamori, H.1
  • 76
    • 79953186624 scopus 로고    scopus 로고
    • FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress
    • Sengupta A., et al. FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress. J. Biol. Chem. 2011, 286:7468-7478.
    • (2011) J. Biol. Chem. , vol.286 , pp. 7468-7478
    • Sengupta, A.1
  • 77
    • 41849093037 scopus 로고    scopus 로고
    • The role of FoxO in the regulation of metabolism
    • Gross D.N., et al. The role of FoxO in the regulation of metabolism. Oncogene 2008, 27:2320-2336.
    • (2008) Oncogene , vol.27 , pp. 2320-2336
    • Gross, D.N.1
  • 78
    • 79955442316 scopus 로고    scopus 로고
    • AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
    • Beauloye C., et al. AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure. Cardiovasc. Res. 2011, 90:224-233.
    • (2011) Cardiovasc. Res. , vol.90 , pp. 224-233
    • Beauloye, C.1
  • 79
    • 33744514139 scopus 로고    scopus 로고
    • Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
    • Cool B., et al. Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome. Cell Metab. 2006, 3:403-416.
    • (2006) Cell Metab. , vol.3 , pp. 403-416
    • Cool, B.1
  • 80
    • 56049112796 scopus 로고    scopus 로고
    • Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes
    • Scott J.W., et al. Thienopyridone drugs are selective activators of AMP-activated protein kinase beta1-containing complexes. Chem. Biol. 2008, 15:1220-1230.
    • (2008) Chem. Biol. , vol.15 , pp. 1220-1230
    • Scott, J.W.1
  • 81
    • 79956298543 scopus 로고    scopus 로고
    • A small molecule AMPK activator protects the heart against ischemia-reperfusion injury
    • Kim A.S., et al. A small molecule AMPK activator protects the heart against ischemia-reperfusion injury. J. Mol. Cell. Cardiol. 2011, 51:24-32.
    • (2011) J. Mol. Cell. Cardiol. , vol.51 , pp. 24-32
    • Kim, A.S.1
  • 82
    • 84901332717 scopus 로고    scopus 로고
    • A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake
    • Timmermans A.D., et al. A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1619-H1630.
    • (2014) Am. J. Physiol. Heart Circ. Physiol. , vol.306 , pp. H1619-H1630
    • Timmermans, A.D.1
  • 83
    • 34547114475 scopus 로고    scopus 로고
    • Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration
    • Zhang L., et al. Metformin and phenformin activate AMP-activated protein kinase in the heart by increasing cytosolic AMP concentration. Am. J. Physiol. Heart Circ. Physiol. 2007, 293:H457-H466.
    • (2007) Am. J. Physiol. Heart Circ. Physiol. , vol.293 , pp. H457-H466
    • Zhang, L.1
  • 84
    • 79961041348 scopus 로고    scopus 로고
    • Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure
    • Yin M., et al. Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H459-H468.
    • (2011) Am. J. Physiol. Heart Circ. Physiol. , vol.301 , pp. H459-H468
    • Yin, M.1
  • 85
    • 79251477152 scopus 로고    scopus 로고
    • Metformin improves cardiac function in rats via activation of AMP-activated protein kinase
    • Wang X.F., et al. Metformin improves cardiac function in rats via activation of AMP-activated protein kinase. Clin. Exp. Pharmacol. Physiol. 2011, 38:94-101.
    • (2011) Clin. Exp. Pharmacol. Physiol. , vol.38 , pp. 94-101
    • Wang, X.F.1
  • 86
    • 66349105917 scopus 로고    scopus 로고
    • Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase
    • Sasaki H., et al. Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase. Circulation 2009, 119:2568-2577.
    • (2009) Circulation , vol.119 , pp. 2568-2577
    • Sasaki, H.1
  • 87
    • 61949300140 scopus 로고    scopus 로고
    • Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure
    • Gundewar S., et al. Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure. Circ. Res. 2009, 104:403-411.
    • (2009) Circ. Res. , vol.104 , pp. 403-411
    • Gundewar, S.1
  • 88
    • 33645730144 scopus 로고    scopus 로고
    • Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart
    • Zhang L., et al. Relationship between 5-aminoimidazole-4-carboxamide-ribotide and AMP-activated protein kinase activity in the perfused mouse heart. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H1235-H1243.
    • (2006) Am. J. Physiol. Heart Circ. Physiol. , vol.290 , pp. H1235-H1243
    • Zhang, L.1
  • 89
    • 33745717084 scopus 로고    scopus 로고
    • Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts
    • Chabowski A., et al. Prolonged AMPK activation increases the expression of fatty acid transporters in cardiac myocytes and perfused hearts. Mol. Cell. Biochem. 2006, 288:201-212.
    • (2006) Mol. Cell. Biochem. , vol.288 , pp. 201-212
    • Chabowski, A.1
  • 90
    • 3543008912 scopus 로고    scopus 로고
    • Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte
    • Chan A.Y., et al. Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J. Biol. Chem. 2004, 279:32771-32779.
    • (2004) J. Biol. Chem. , vol.279 , pp. 32771-32779
    • Chan, A.Y.1
  • 91
    • 84905014655 scopus 로고    scopus 로고
    • AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1
    • Li Y., et al. AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch. Biochem. Biophys. 2014, 558:79-86.
    • (2014) Arch. Biochem. Biophys. , vol.558 , pp. 79-86
    • Li, Y.1
  • 92
    • 79958793890 scopus 로고    scopus 로고
    • AMPK activation enhances PPARalpha activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway
    • Meng R., et al. AMPK activation enhances PPARalpha activity to inhibit cardiac hypertrophy via ERK1/2 MAPK signaling pathway. Arch. Biochem. Biophys. 2011, 511:1-7.
    • (2011) Arch. Biochem. Biophys. , vol.511 , pp. 1-7
    • Meng, R.1
  • 93
    • 84862509994 scopus 로고    scopus 로고
    • Resveratrol in cardiovascular disease: what is known from current research?
    • Wang H., et al. Resveratrol in cardiovascular disease: what is known from current research?. Heart Fail. Rev. 2012, 17:437-448.
    • (2012) Heart Fail. Rev. , vol.17 , pp. 437-448
    • Wang, H.1
  • 94
    • 53049091294 scopus 로고    scopus 로고
    • Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt
    • Chan A.Y., et al. Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J. Biol. Chem. 2008, 283:24194-24201.
    • (2008) J. Biol. Chem. , vol.283 , pp. 24194-24201
    • Chan, A.Y.1
  • 95
    • 84879563896 scopus 로고    scopus 로고
    • Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice
    • Dolinsky V.W., et al. Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim. Biophys. Acta 2013, 1832:1723-1733.
    • (2013) Biochim. Biophys. Acta , vol.1832 , pp. 1723-1733
    • Dolinsky, V.W.1
  • 96
    • 84886573158 scopus 로고    scopus 로고
    • Resveratrol mainly stimulates the glycolytic ATP synthesis flux and not the mitochondrial one: a saturation transfer NMR study in perfused and isolated rat liver
    • Beauvieux M-C., et al. Resveratrol mainly stimulates the glycolytic ATP synthesis flux and not the mitochondrial one: a saturation transfer NMR study in perfused and isolated rat liver. Pharmacol. Res. 2013, 78:11-17.
    • (2013) Pharmacol. Res. , vol.78 , pp. 11-17
    • Beauvieux, M.-C.1
  • 97
    • 77950348878 scopus 로고    scopus 로고
    • AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol
    • Um J-H., et al. AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. Diabetes 2010, 59:554-563.
    • (2010) Diabetes , vol.59 , pp. 554-563
    • Um, J.-H.1
  • 98
    • 80054736902 scopus 로고    scopus 로고
    • Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure
    • Rimbaud S., et al. Resveratrol improves survival, hemodynamics and energetics in a rat model of hypertension leading to heart failure. PLoS ONE 2011, 6:e26391.
    • (2011) PLoS ONE , vol.6 , pp. e26391
    • Rimbaud, S.1
  • 99
    • 84907443927 scopus 로고    scopus 로고
    • Protective effect of resveratrol against pressure overload-induced heart failure
    • Gupta P.K., et al. Protective effect of resveratrol against pressure overload-induced heart failure. Food Sci. Nutr. 2014, 2:218-229.
    • (2014) Food Sci. Nutr. , vol.2 , pp. 218-229
    • Gupta, P.K.1
  • 100
    • 77950901103 scopus 로고    scopus 로고
    • Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure
    • Tanno M., et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J. Biol. Chem. 2010, 285:8375-8382.
    • (2010) J. Biol. Chem. , vol.285 , pp. 8375-8382
    • Tanno, M.1
  • 101
    • 49549114451 scopus 로고    scopus 로고
    • Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats
    • Lin J.F., et al. Resveratrol reduces infarct size and improves ventricular function after myocardial ischemia in rats. Life Sci. 2008, 83:313-317.
    • (2008) Life Sci. , vol.83 , pp. 313-317
    • Lin, J.F.1
  • 102
    • 84893909601 scopus 로고    scopus 로고
    • Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure
    • Gu X.S., et al. Resveratrol, an activator of SIRT1, upregulates AMPK and improves cardiac function in heart failure. Genet. Mol. Res. 2014, 13:323-335.
    • (2014) Genet. Mol. Res. , vol.13 , pp. 323-335
    • Gu, X.S.1
  • 103
    • 49649128985 scopus 로고    scopus 로고
    • Mitochondrial biogenesis and healthy aging
    • Lopez-Lluch G., et al. Mitochondrial biogenesis and healthy aging. Exp. Gerontol. 2008, 43:813-819.
    • (2008) Exp. Gerontol. , vol.43 , pp. 813-819
    • Lopez-Lluch, G.1
  • 104
    • 0025353029 scopus 로고
    • Diastolic dysfunction and myocardial energetics
    • Pouleur H. Diastolic dysfunction and myocardial energetics. Eur. Heart J. 1990, 11(Suppl. C):30-34.
    • (1990) Eur. Heart J. , vol.11 , pp. 30-34
    • Pouleur, H.1
  • 105
    • 51549114941 scopus 로고    scopus 로고
    • Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt
    • Kato M.F., et al. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt. J. Hypertens. 2008, 26:1669-1676.
    • (2008) J. Hypertens. , vol.26 , pp. 1669-1676
    • Kato, M.F.1
  • 106
    • 79952070936 scopus 로고    scopus 로고
    • Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction
    • Turdi S., et al. Deficiency in AMP-activated protein kinase exaggerates high fat diet-induced cardiac hypertrophy and contractile dysfunction. J. Mol. Cell. Cardiol. 2011, 50:712-722.
    • (2011) J. Mol. Cell. Cardiol. , vol.50 , pp. 712-722
    • Turdi, S.1
  • 107
    • 29344440492 scopus 로고    scopus 로고
    • Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database
    • Yancy C.W., et al. Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the Acute Decompensated Heart Failure National Registry (ADHERE) Database. J. Am. Coll. Cardiol. 2006, 47:76-84.
    • (2006) J. Am. Coll. Cardiol. , vol.47 , pp. 76-84
    • Yancy, C.W.1
  • 108
    • 84881254144 scopus 로고    scopus 로고
    • Metformin therapy in diabetes: the role of cardioprotection
    • El Messaoudi S., et al. Metformin therapy in diabetes: the role of cardioprotection. Curr. Atheroscler. Rep. 2013, 15:314.
    • (2013) Curr. Atheroscler. Rep. , vol.15 , pp. 314
    • El Messaoudi, S.1
  • 109
    • 34547926839 scopus 로고    scopus 로고
    • LKB1 modulates lung cancer differentiation and metastasis
    • Ji H., et al. LKB1 modulates lung cancer differentiation and metastasis. Nature 2007, 448:807-810.
    • (2007) Nature , vol.448 , pp. 807-810
    • Ji, H.1
  • 110
    • 84900818845 scopus 로고    scopus 로고
    • Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice
    • Baltgalvis K.A., et al. Exercise performance and peripheral vascular insufficiency improve with AMPK activation in high-fat diet-fed mice. Am. J. Physiol. Heart Circ. Physiol. 2014, 306:H1128-H1145.
    • (2014) Am. J. Physiol. Heart Circ. Physiol. , vol.306 , pp. H1128-H1145
    • Baltgalvis, K.A.1
  • 111
    • 84881255684 scopus 로고    scopus 로고
    • ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK
    • Filippov S., et al. ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK. J. Lipid Res. 2013, 54:2095-2108.
    • (2013) J. Lipid Res. , vol.54 , pp. 2095-2108
    • Filippov, S.1
  • 112
    • 84884366154 scopus 로고    scopus 로고
    • Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial
    • Ballantyne C.M., et al. Efficacy and safety of a novel dual modulator of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase in patients with hypercholesterolemia: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial. J. Am. Coll. Cardiol. 2013, 62:1154-1162.
    • (2013) J. Am. Coll. Cardiol. , vol.62 , pp. 1154-1162
    • Ballantyne, C.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.